EGF anticorps (AA 1090-1094)

N° du produit ABIN5689363

L’anticorps Lapin Polyclonal anti-EGF a été validé pour WB et IHC. Il convient pour détecter EGF dans des échantillons de Humain, Souris et Rat.

Aperçu rapide pour EGF anticorps (AA 1090-1094) (ABIN5689363)

Antigène: EGF (Epidermal Growth Factor (EGF))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EGF est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-EGF anticorps

Épitope: AA 1090-1094

Specificité: This antibody detects endogenous level of total EGFR protein.

Purification: Antibodies were purified by affinity-chromatography using epitope-specific peptide.

Immunogène: EGFR (Ab-1092) antibody was raised against a peptide sequence around aa. 1090~1094 (P-E-Y-I-N) derived from Human EGFR.

Information d'application

Indications d'application: Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+),  pH 7.4, 150  mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store antibody at -20°C for up to one year.

Détails sur EGF

Antigène: EGF (Epidermal Growth Factor (EGF))

Autre désignation: EGF

Sujet: Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentia

Poids moléculaire: 175 kDa

ID gène: 1956

NCBI Accession: NP_005219

UniProt: P00533

Pathways: Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation